Quest Diagnostics (DGX) Enterprise Value (2009 - 2026)

Quest Diagnostics has disclosed Enterprise Value across 18 years of filings, most recently posting -$93.0 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$93.0 million, up 40.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$93.0 million (up 40.0% YoY), and the FY2025 annual result was -$384.0 million, up 25.29% from the prior year.
• Enterprise Value came in at -$93.0 million for Q1 2026 at Quest Diagnostics, up from -$384.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$49.0 million in Q2 2023 to a low of -$751.0 million in Q2 2022.
• The 5-year median for Enterprise Value is -$351.0 million (2025), against an average of -$367.1 million.
• Across the five-year window, Enterprise Value jumped 93.48% in 2023 and plunged 920.9% in 2024, its largest moves.
• Quest Diagnostics' Enterprise Value stood at -$238.0 million in 2022, then sank by 156.3% to -$610.0 million in 2023, then advanced by 15.74% to -$514.0 million in 2024, then advanced by 25.29% to -$384.0 million in 2025, then jumped by 75.78% to -$93.0 million in 2026.
• The last three Enterprise Value figures came in at -$93.0 million (Q1 2026), -$384.0 million (Q4 2025), and -$351.0 million (Q3 2025), per Business Quant data.